POLYMORPHISMS OF HUMAN AH RECEPTOR GENE ARE NOT INVOLVED IN LUNG-CANCER

被引:86
作者
KAWAJIRI, K
WATANABE, J
EGUCHI, H
NAKACHI, K
KIYOHARA, C
HAYASHI, S
机构
[1] SAITAMA CANC CTR, RES INST, DEPT EPIDEMIOL, INA, SAITAMA 362, JAPAN
[2] KYUSHU UNIV, FAC MED, DEPT PUBL HLTH, HIGASHI KU, FUKUOKA 812, JAPAN
来源
PHARMACOGENETICS | 1995年 / 5卷 / 03期
关键词
LUNG CANCER; GENETIC POLYMORPHISM; AHH; AHR;
D O I
10.1097/00008571-199506000-00003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The Ah receptor (Ahr) is a ligand-dependent transcription factor that positively regulates inducible expression of the CYP1A1 gene, Based on the sequence information of the human Ahr and the intron-exon junctions of the mouse counterpart, an analysis of single-strand conformational polymorphism (SSCP) was carried out to detect subtle base differences in the coding region of the gene among individuals, We found that the Ahr protein has at least two forms of variants in a Japanese gene pool, and that these variants can be ascribed to one amino acid replacement of Arg by Lys at codon 554, The frequencies of Arg-coded and Lys-coded alleles were 0.57 and 0.43, respectively, We found, however, that this germ line polymorphism of the Ahr gene did not show a significant association with aryl hydrocarbon hydroxylase (AHH) inducibility nor with lung cancer incidence.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 27 条
  • [1] CLONING OF THE AH-RECEPTOR CDNA REVEALS A DISTINCTIVE LIGAND-ACTIVATED TRANSCRIPTION FACTOR
    BURBACH, KM
    POLAND, A
    BRADFIELD, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 8185 - 8189
  • [2] RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE
    CAPORASO, N
    LANDI, MT
    VINEIS, P
    [J]. PHARMACOGENETICS, 1991, 1 (01): : 4 - 19
  • [3] 10 NUCLEOTIDE DIFFERENCES, 5 OF WHICH CAUSE AMINO-ACID CHANGES, ARE ASSOCIATED WITH THE AH RECEPTOR LOCUS POLYMORPHISM OF C57BL/6 AND DBA/2 MICE
    CHANG, CY
    SMITH, DR
    PRASAD, VS
    SIDMAN, CL
    NEBERT, DW
    PUGA, A
    [J]. PHARMACOGENETICS, 1993, 3 (06): : 312 - 321
  • [4] DOLWICK KM, 1993, MOL PHARMACOL, V44, P911
  • [5] EMA M, 1994, J BIOL CHEM, V269, P27337
  • [6] CDNA CLONING AND STRUCTURE OF MOUSE PUTATIVE AH RECEPTOR
    EMA, M
    SOGAWA, K
    WATANABE, N
    CHUJOH, Y
    MATSUSHITA, N
    GOTOH, O
    FUNAE, Y
    FUJIIKURIYAMA, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (01) : 246 - 253
  • [7] GENETIC-LINKAGE OF LUNG CANCER-ASSOCIATED MSPI POLYMORPHISMS WITH AMINO-ACID REPLACEMENT IN THE HEME BINDING REGION OF THE HUMAN CYTOCHROME-P450IA1 GENE
    HAYASHI, S
    WATANABE, J
    NAKACHI, K
    KAWAJIRI, K
    [J]. JOURNAL OF BIOCHEMISTRY, 1991, 110 (03) : 407 - 411
  • [8] INTERINDIVIDUAL DIFFERENCE IN EXPRESSION OF HUMAN AH RECEPTOR AND RELATED P450 GENES
    HAYASHI, S
    WATANABE, J
    NAKACHI, K
    EGUCHI, H
    GOTOH, O
    KAWAJIRI, K
    [J]. CARCINOGENESIS, 1994, 15 (05) : 801 - 806
  • [9] HIGH SUSCEPTIBILITY TO LUNG-CANCER ANALYZED IN TERMS OF COMBINED GENOTYPES OF P450IA1 AND MU-CLASS GLUTATHIONE-S-TRANSFERASE GENES
    HAYASHI, S
    WATANABE, J
    KAWAJIRI, K
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (08): : 866 - 870
  • [10] P450 AND HUMAN CANCER
    KAWAJIRI, K
    FUJIIKURIYAMA, Y
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (12): : 1325 - 1335